Americans are using more prescription drugs than ever. Consequently, they’re coping with more side effects, drug interactions, and costs, especially if they’re using multiple medications. Kaiser Permanente Washington Health Research Institute (KPWHRI) scientists are on the forefront of answering questions about these concerns. We’re studying the beneficial and harmful effects of medications in real-world settings, and innovating better ways to manage and monitor drug use.
The institute contributes to national initiatives to monitor medication safety as well as providing information to help doctors and patients weigh the risks and benefits of various prescription drugs.
Funders of KPWHRI medication use and patient safety research include the Centers for Disease Control and Prevention, the U.S. Food and Drug Administration, the National Institutes of Health, the Patient-Centered Outcomes Research Institute, and other sources. A few projects include:
Haynes RB, Sandler RS, Larson EB, Pater JL, Yatsu FM. A critical appraisal of ticlopidine, a new antiplatelet agent. Effectiveness and clinical indications for prophylaxis of atherosclerotic events. Arch Intern Med. 1992;152(7):1376-80. PubMed
Nuovo J, Ellsworth AJ, Larson EB. Treatment of atopic dermatitis with antihistamines: lessons from a single-patient, randomized clinical trial. J Am Board Fam Pract. 1992;5(2):137-41. PubMed
Stuart ME, Handley MA, Chamberlain MA, Wallach RW, Penna PM, Stergachis A. Successful implementation of a guideline program for the rational use of lipid-lowering drugs. HMO Pract. 1991;5(6):198-204. PubMed
Heidrich F, Stergachis A, Gross K. Diuretic drug use and the risk for hip fracture. Ann Intern Med. 1991;115(1):1-6. PubMed
Psaty BM, Koepsell TD, Siscovick D, Wahl P, Logerfo JP, Inui TS, Wagner EH. An approach to several problems in using large databases for population-based case-control studies of therapeutic efficacy and safety of anti-hypertensive medicine. Stat Med. 1991;10(4):653-62. PubMed
![]() Sascha Dublin, MD, PhDSenior Investigator |
![]() Jessica Chubak, PhDSenior Investigator |
![]() Andrea J. Cook, PhDSenior Biostatistics Investigator |
![]() Rita Mangione-Smith, MD, MPHExecutive Director and Senior Investigator, KPWHRI; Vice President for Research and Health Care Innovation, Kaiser Permanente Washington |
![]() Eric B. Larson, MD, MPH, MACPSenior Investigator and former Executive Director, KPWHRI; Former Vice President for Research and Health Care Innovation, KPWA |
![]() Jennifer C. Nelson, PhDDirector, Biostatistics; Senior Investigator |
![]() David E. Arterburn, MD, MPHSenior Investigator |
![]() Susan M. Shortreed, PhDSenior Biostatistics Investigator |
![]() Lisa A. Jackson, MD, MPHSenior Investigator |
![]() Karen Wernli, PhDAssociate Investigator |
![]() Onchee Yu, MSSenior Collaborative Biostatistician |
![]() Rod L. Walker, MSSenior Collaborative Biostatistician |
![]() Robert D. Wellman, MSSenior Collaborative Biostatistician |
![]() Gaia Pocobelli, PhDCollaborative Scientist |
![]() David S. Carrell, PhDAssociate Investigator |
![]() Laura Harrington, PhD, MPHAssistant Investigator |
![]() Jennifer F. Bobb, PhDAssociate Biostatistics Investigator |
![]() Weiwei Zhu, MSSenior Collaborative Biostatistician |
![]() Paige D. Wartko, PhD, MPHCollaborative Scientist |
![]() Maricela Cruz, PhDAssistant Biostatistics Investigator |
![]() Brian D. Williamson, PhDAssistant Biostatistics Investigator |
![]() Noorie Hyun, PhDAssistant Biostatistics Investigator |
![]() Laurel Hansell, MA, MPHCollaborative Scientist |
![]() Jess Mogk, MPHCollaborative Scientist |
Susan Heckbert, MD, PhD
University of Washington (UW) Department of Epidemiology; UW Cardiovascular Health Research Unit
David Siscovick, MD, MPH
UW Department of Medicine; UW Department of Epidemiology; UW Cardiovascular Health Research Unit
Leslie Spangler, PhD
Amgen